In Brazil, education emerges as the top factor influencing cognitive decline, revealing significant health disparities affecting brain health in Latin America.
Santhera introduces AGAMREE for DMD treatment in Germany
Share this article In the VISION-DMD study, vamorolone demonstrated a robust safety and tolerability profile in the treatment of Duchenne muscular dystrophy. Credit: Aleksandra Berzhets/Shutterstock.com